Lipid-lowering Therapy Individualization

• Status: Completed
• Trial end date: 2019-08-27
• Target enrollment: 0
• Participant gender: All

Summary

This clinical study will explore individual factors influencing statin pharmacokinetics in a cohort of 150 patients treated with atorvastatin.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Université Catholique de Louvain
• Collaborator: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
• Treatments: Atorvastatin; Atorvastatin Calcium

Criteria

Inclusion Criteria:

• Treatment with atorvastatin (any dose)

Exclusion Criteria:

• Unable to provide informed consent